WallStreetZenWallStreetZen

NASDAQ: BCAL
Southern California Bancorp Stock

$14.14+0.04 (+0.28%)
Updated Apr 26, 2024
BCAL Price
$14.14
Fair Value Price
N/A
Market Cap
$260.62M
52 Week Low
$13.00
52 Week High
$18.00
P/E
9.96x
P/B
0.9x
P/S
3.29x
PEG
0.35x
Dividend Yield
N/A
Revenue
$96.60M
Earnings
$25.91M
Gross Margin
100%
Operating Margin
38.15%
Profit Margin
26.8%
Debt to Equity
7.19
Operating Cash Flow
$33M
Beta
0.41
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

Zen Score

Industry Average (33)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how BCAL scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

BCAL ($14.14) is trading below its intrinsic value of $21.75, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
BCAL is good value based on its earnings relative to its share price (9.96x), compared to the US market average (41.14x)
P/E vs Market Valuation
BCAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more BCAL due diligence checks available for Premium users.

Be the first to know about important BCAL news, forecast changes, insider trades & much more!

BCAL News

Valuation

BCAL price to earnings (PE)

For valuing profitable companies with steady earnings
Company
9.96x
Industry
-9.61x
Market
41.14x
BCAL is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
BCAL is good value based... subscribe to Premium to read more.
P/E vs Market Valuation

BCAL price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.9x
Industry
0.99x
BCAL is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

BCAL price to earnings growth (PEG)

For valuing profitable companies with growth potential
BCAL is good value based... subscribe to Premium to read more.
PEG Value Valuation

BCAL's financial health

Profit margin

Revenue
$21.6M
Net Income
$4.4M
Profit Margin
20.4%
BCAL's Earnings (EBIT) of $36.86M... subscribe to Premium to read more.
Interest Coverage Financials
BCAL's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$2.4B
Liabilities
$2.1B
Debt to equity
7.19
BCAL's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$8.4M
Investing
-$36.2M
Financing
$36.3M
BCAL's operating cash flow ($33.10M)... subscribe to Premium to read more.
Debt Coverage Financials

BCAL vs Bank Stocks

TickerMarket Cap1d %P/EP/B
BCAL$260.62M+0.28%9.96x0.90x
VBNK$259.12M+0.71%7.94x0.91x
FDBC$263.31M+0.86%14.31x1.39x
SBT$257.74M+2.06%33.00x0.79x
OBT$253.91M+1.98%8.56x1.54x

Southern California Bancorp Stock FAQ

What is Southern California Bancorp's quote symbol?

(NASDAQ: BCAL) Southern California Bancorp trades on the NASDAQ under the ticker symbol BCAL. Southern California Bancorp stock quotes can also be displayed as NASDAQ: BCAL.

If you're new to stock investing, here's how to buy Southern California Bancorp stock.

What is the 52 week high and low for Southern California Bancorp (NASDAQ: BCAL)?

(NASDAQ: BCAL) Southern California Bancorp's 52-week high was $18.00, and its 52-week low was $13.00. It is currently -21.44% from its 52-week high and 8.77% from its 52-week low.

How much is Southern California Bancorp's stock price per share?

(NASDAQ: BCAL) Southern California Bancorp stock price per share is $14.14 today (as of Apr 26, 2024).

What is Southern California Bancorp's Market Cap?

(NASDAQ: BCAL) Southern California Bancorp's market cap is $260.62M, as of Apr 27, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Southern California Bancorp's market cap is calculated by multiplying BCAL's current stock price of $14.14 by BCAL's total outstanding shares of 18,431,409.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.